Israel Englander’s Bausch Health BHC Stock Holding History

Israel Englander’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,900	Closed	-$68K	–	6373
2022 Q4	$68K	Buy	+10,900	New	+$76.1K	﹤0.01%	5698
2022 Q1	–	Sell	-310,800	Closed	-$8.58M	–	6906
2021 Q4	$8.58M	Buy	310,800 +162,100	+109%	+$4.34M	﹤0.01%	2309
2021 Q3	$4.14M	Sell	148,700 -281,000	-65%	-$7.97M	﹤0.01%	3089
2021 Q2	$12.6M	Buy	429,700 +175,700	+69%	+$5.32M	0.01%	1643
2021 Q1	$8.06M	Buy	+254,000	New	+$7.45M	0.01%	2026
2020 Q2	–	Sell	-40,100	Closed	-$622K	–	4164
2020 Q1	$622K	Buy	+40,100	New	+$967K	﹤0.01%	2754
2016 Q1	–	Sell	-75,000	Closed	-$7.62M	–	3264
2015 Q4	$7.62M	Buy	+75,000	New	+$8.43M	0.02%	1082
2015 Q2	–	Sell	-3,500	Closed	-$695K	–	3321
2015 Q1	$695K	Buy	+3,500	New	+$621K	﹤0.01%	2541
2014 Q4	–	Sell	-46,200	Closed	-$6.06M	–	3914
2014 Q3	$6.06M	Buy	+46,200	New	+$5.51M	0.02%	1175
2014 Q2	–	Sell	-9,800	Closed	-$1.29M	–	3400
2014 Q1	$1.29M	Buy	9,800 +3,600	+58%	+$492K	﹤0.01%	2074
2013 Q4	$728K	Buy	+6,200	New	+$679K	﹤0.01%	2487

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Israel Englander's BHC Position: Q2 2026 in Review

Israel Englander increased its Bausch Health (BHC) stake by 151% in Q2 2026, buying an estimated $3.53M and bringing the position to 1,095,104 shares worth $5.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Israel Englander first reported a position in BHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $232M in Q2 2015. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Israel Englander held 1,095,104 shares of Bausch Health worth $5.39M as of Q2 2026.
Israel Englander bought 658,349 Bausch Health shares in Q2 2026, an estimated $3.53M.
Bausch Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2933 holding.
Israel Englander first reported a position in Bausch Health in Q2 2013 and has held it in 50 quarters since.
Israel Englander's Bausch Health position peaked at $232M in Q2 2015.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.